In a promising development in the fight against tuberculosis (TB), scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) have identified critical weaknesses in the bacteria responsible for the disease. The discovery could help researchers develop new treatments, particularly against drug-resistant TB, which remains a major public health concern in India and across the world.
New Hope in the Fight Against TB
The research team at CSIR-CCMB identified potential new targets in Mycobacterium tuberculosis, the bacterium that causes tuberculosis. These findings could support the development of new medicines and treatment approaches to fight the disease.
Tuberculosis continues to be one of the world’s deadliest infectious diseases. Treatment generally involves a combination of antibiotics taken over several months. However, the growing problem of drug resistance is making treatment more challenging, as some TB bacteria no longer respond effectively to commonly used medicines.
Why Is This Discovery Important for India?
The findings are particularly important for India, which carries a significant share of the global TB burden.
According to the World Health Organization’s (WHO) Global Tuberculosis Report 2025, India accounts for nearly one-fourth of all TB cases worldwide and around one-third of drug-resistant TB infections.
Drug-resistant tuberculosis is especially difficult to treat. Patients may need longer treatment courses and combinations of medicines, while the risk of treatment failure remains a major concern.
Identifying new weaknesses in TB-causing bacteria could help scientists find alternative ways to attack the infection and overcome some of the challenges associated with existing treatments.
What Could Happen Next?
The CCMB team’s findings offer a potential starting point for further research into new TB medicines. Scientists will need to conduct additional studies to understand how these targets can be used to develop effective treatments.
Although the discovery does not mean that a new TB drug is immediately available, it represents an encouraging step towards improving treatment options.
With drug-resistant TB continuing to threaten public health, research into new treatment targets is becoming increasingly important.
The findings highlight the role of Indian scientific institutions in tackling major health challenges and supporting the global effort to eliminate tuberculosis.
For more health-related news
Follow Health in Five on LinkedIn & Facebook
